title: Eight-year clinical outcome after radioactive stent implantation: a treatment failure without irreversible long-term clinical sequelae.
abstract: OBJECTIVE
  To assess the long-term outcome of patients who underwent radioactive stent (RS) implantation.
  
  
  RESULTS
  The RS study population consisted of 133 consecutive patients who underwent RS implantation between November 1997 and July 2000. They were matched using the propensity score method with 266 patients who underwent bare metal stenting (BMS) in the same span. Long-term survival status and information on MACE (death, non-fatal myocardial infarction or any re-intervention) was retrospectively obtained. Eight-year cumulative survival (90.2% vs. 87.4%, p = 0.57) was similar between the RS and BMS group respectively, while 8-year cumulative MACE-free survival was significantly lower in RS patients (42.1% vs. 64.3%, p < 0.001) due to the difference in events (mainly target lesion revascularisations [TLRs]) during the first year of follow-up (cumulative 1-year MACE-free survival: 59.4% vs. 86.7%, p < 0.001); there was no difference in the MACE rate after the first year (p = 0.71). The TLR rate at six months in the RS group was 29.3%, mainly due to edge restenosis and at one year 36.2% (control group: 9.5%, p < 0.001).
  
  
  CONCLUSIONS
  A high incidence of MACE and re-intervention was observed during the first year following RS implantation, mainly related to TLR for edge restenosis. After the first year, the clinical outcome of RS patients was similar to the control group indicating that there are no late adverse effects related to low dose-rate intracoronary radiation therapy.
authors.affiliation: Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands. gsianos@guth.gr
authors.forename: Georgios
authors.initials: G
authors.lastname: Sianos
authors.forename: Michail I
authors.initials: MI
authors.lastname: Papafaklis
authors.forename: Ron
authors.initials: R
authors.lastname: van Domburg
authors.forename: Denise
authors.initials: D
authors.lastname: Adams
authors.forename: Josephine Wi
authors.initials: JW
authors.lastname: van Nierop
authors.forename: Willem J
authors.initials: WJ
authors.lastname: van der Giessen
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D001918:Brachytherapy / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D016009:Chi-Square Distribution; D003324:Coronary Artery Disease / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D023903:Coronary Restenosis / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008670:Metals; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000628:therapy; D009426:Netherlands; D057216:Propensity Score; D011474:Prosthesis Design; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents; D015996:Survival Rate; D013997:Time Factors; D017211:Treatment Failure
chemical_list: D008670:Metals